Literature DB >> 18398601

Serotonin pharmacology in the gastrointestinal tract: a review.

D T Beattie1, J A M Smith.   

Abstract

Serotonin (5-hydroxytryptamine or 5-HT) plays a critical physiological role in the regulation of gastrointestinal (GI) function. 5-HT dysfunction may also be involved in the pathophysiology of a number of functional GI disorders, such as chronic constipation, irritable bowel syndrome and functional dyspepsia. This article describes the role of 5-HT in the enteric nervous system (ENS) of the mammalian GI tract and the receptors with which it interacts. Existing serotonergic therapies that have proven effective in the treatment of GI functional disorders and the potential of drugs currently in development are also highlighted. Advances in our understanding of the physiological and pathophysiological roles of 5-HT in the ENS and the identification of selective receptor ligands bodes well for the future development of more efficacious therapies for patients with functional GI disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398601     DOI: 10.1007/s00210-008-0276-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  286 in total

1.  5-Hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: a polymerase chain reaction study.

Authors:  P A Pierce; G X Xie; T Meuser; S J Peroutka
Journal:  Neuroscience       Date:  1997-12       Impact factor: 3.590

2.  Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects.

Authors:  B Coffin; J-P Farmachidi; P Rueegg; A Bastie; D Bouhassira
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

3.  Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Ferber; Debra Stephens; Thomas C Smyrk; Raul Urrutia; Jeroen Aerssens; Leen Thielemans; Hinrich Göhlmann; Ilse van den Wyngaert; Bernard Coulie
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

4.  Effect of tegaserod on gut transit in male and female subjects.

Authors:  L Degen; C Petrig; D Studer; S Schroller; C Beglinger
Journal:  Neurogastroenterol Motil       Date:  2005-12       Impact factor: 3.598

5.  Effect of sumatriptan, a 5HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects.

Authors:  D Sifrim; R H Holloway; J Tack; A Zelter; T Missotten; B Coulie; J Janssens
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

Review 6.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  The 5-hydroxytryptamine(4a) receptor is palmitoylated at two different sites, and acylation is critically involved in regulation of receptor constitutive activity.

Authors:  Evgeni G Ponimaskin; Martin Heine; Lara Joubert; Michele Sebben; Ulf Bickmeyer; Diethelm W Richter; Aline Dumuis
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

8.  A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.

Authors:  M Ruat; E Traiffort; J M Arrang; J Tardivel-Lacombe; J Diaz; R Leurs; J C Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

9.  Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: a homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity.

Authors:  M W Hamblin; M A Metcalf; R W McGuffin; S Karpells
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

10.  Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model.

Authors:  Satoru Tamaoki; Yukinao Yamauchi; Youichi Nakano; Sayuri Sakano; Akira Asagarasu; Michitaka Sato
Journal:  J Pharmacol Exp Ther       Date:  2007-05-31       Impact factor: 4.030

View more
  43 in total

1.  Duodenal calcium transporter mRNA expression in stressed male rats treated with diazepam, fluoxetine, reboxetine, or venlafaxine.

Authors:  Narattaphol Charoenphandhu; Jarinthorn Teerapornpuntakit; Sarawut Lapmanee; Nateetip Krishnamra; Jantarima Charoenphandhu
Journal:  Mol Cell Biochem       Date:  2012-07-06       Impact factor: 3.396

2.  Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.

Authors:  Gareth J Sanger; Lin Chang; Chas Bountra; Lesley A Houghton
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

3.  Inhibition of colonic motility and defecation by RS-127445 suggests an involvement of the 5-HT2B receptor in rodent large bowel physiology.

Authors:  A K Bassil; C M Taylor; V J N Bolton; K M Gray; J D Brown; L Cutler; S G Summerfield; G Bruton; W J Winchester; K Lee; G J Sanger
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

4.  Brain serotonergic circuitries.

Authors:  Yves Charnay; Lucienne Léger
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

5.  5-hydroxytryptamine generates tonic inward currents on pacemaker activity of interstitial cells of cajal from mouse small intestine.

Authors:  Pawan Kumar Shahi; Seok Choi; Dong Chuan Zuo; Cheol Ho Yeum; Pyung Jin Yoon; Jun Lee; Young Dae Kim; Chan Guk Park; Man Yoo Kim; Hye Rang Shin; Hyun Jung Oh; Jae Yeoul Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-06-30       Impact factor: 2.016

Review 6.  The 5-HT(7) receptor in learning and memory.

Authors:  Amanda J Roberts; Peter B Hedlund
Journal:  Hippocampus       Date:  2011-04-11       Impact factor: 3.899

Review 7.  Duodenal Chemosensing of Short-Chain Fatty Acids: Implications for GI Diseases.

Authors:  Mari Iwasaki; Yasutada Akiba; Jonathan D Kaunitz
Journal:  Curr Gastroenterol Rep       Date:  2019-07-10

Review 8.  The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D).

Authors:  Yang Won Min; Poong-Lyul Rhee
Journal:  Therap Adv Gastroenterol       Date:  2015-05       Impact factor: 4.409

9.  Serotonin and the GI tract.

Authors:  William L Hasler
Journal:  Curr Gastroenterol Rep       Date:  2009-10

10.  Depression, anxiety and anger in subtypes of irritable bowel syndrome patients.

Authors:  Maria Rosaria A Muscatello; Antonio Bruno; Gianluca Pandolfo; Umberto Micò; Simona Stilo; Mariagrazia Scaffidi; Pierluigi Consolo; Andrea Tortora; Socrate Pallio; Giuseppa Giacobbe; Luigi Familiari; Rocco Zoccali
Journal:  J Clin Psychol Med Settings       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.